Filing Details
- Accession Number:
- 0001209191-19-025125
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-04-17 18:05:35
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-04-17 18:05:35
- Original Submission Date:
- 2019-03-04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1303811 | Richard Thomas Kassberg | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Cbo & Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-01 | 7,000 | $0.00 | 90,306 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-03-05 | 832 | $65.52 | 89,474 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-03-01 | 21,500 | $0.00 | 21,500 | $67.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,500 | 2029-03-01 | No | 4 | A | Direct |
Footnotes
- Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- Includes 191 shares acquired under the Company's 2014 Employee Stock Purchase Plan.
- Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units.
- On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Billionaire Hedge Funds
